TNF and uveitis: As a result of such observations, etanercept is not routinely used as a first-line agent in the management of BD-related uveitis: In a 2014 systematic review, Levy-Clarke et al. made recommendations for the use of anti-TNF biologic agents in patients with ocular inflammatory conditions.